Patients News | pharmaphorum

News

Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again.

News

Biogen has started a new phase 3 trial that aims to extend the use of its Friedreich's ataxia drug Skyclarys to patients as young as two.

News

People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.

News

RFK Jr's interference in the ACIP is putting patients at risk, claim the 17 members of the panel abruptly fired last week.

News

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.

News

Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.